Mens Recovery Program Residential Reintegration

Mens Recovery Program Residential Reintegration

Services:
Facility Smoking Policy
• Smoking permitted in designated area

Testing

• Drug or alcohol urine screening
• TB screening
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing

Recovery Support Services

• Assistance with obtaining social services
• Housing services

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment
• Medicaid
• SAMHSA funding/block grants
• Federal, or any government funding for substance use treatment programs

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Type of Opioid Treatment

• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere

Treatment Approaches

• Brief intervention
• Relapse prevention
• Motivational interviewing
• Cognitive behavioral therapy
• Anger management
• Substance use disorder counseling

Gender Accepted

• Male

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Long-term residential

Education and Counseling Services

• Group counseling
• Smoking/vaping/tobacco cessation counseling
• Substance use disorder education
• Individual counseling

Assessment/Pre-treatment

• Screening for substance use
• Screening for tobacco use
• Comprehensive substance use assessment
• Screening for mental disorders

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Age Groups Accepted

• Young Adults
• Adults
• Seniors

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Pharmacotherapies

• Naltrexone (extended-release, injectable)
• Disulfiram
• Buprenorphine with naloxone
• Acamprosate (Campral�)
• Clonidine
• Medication for mental disorders
• Non-nicotine smoking/tobacco cessation
• Naltrexone (oral)
• Nicotine replacement

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Special Programs/Groups Offered

• Adult men

External Opioid Medications Source

• No formal relationship with prescribing entity
• In-network prescribing entity

Facility Vaping Policy

• Vaping not permitted

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

License/Certification/Accreditation

• State Substance use treatment agency

Ancillary Services

• Social skills development
• Case management service